Global Head And Neck Cancer Diagnostics Market 2024 - By Growth Opportunities, Future Insights, Regional Segments, Latest Innovations And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Head And Neck Cancer Diagnostics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $3.32 billion In 2028 At A CAGR Of 16.7%.

The head and neck cancer diagnostics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 18.4%. The growth in the historic period can be attributed to tobacco and alcohol consumption, increasing aging population, awareness campaigns, biopsy techniques development, healthcare infrastructure development.

The head and neck cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to genomic biomarkers, rising incidence of hpv-related cancers, integration of artificial intelligence (ai), immunotherapy and targeted therapies, healthcare policy and reimbursement changes. Major trends in the forecast period include liquid biopsy dominance, multi-modality diagnostics, point-of-care diagnostics, global collaborations and partnerships, digital pathology integration.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12016&type=smp

Head And Neck Cancer Diagnostics Market Major Segments
The head and neck cancer diagnostics market covered in this report is segmented -

1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail and Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users

Key Driver - Rising Prevalence Of Head And Neck Cancer To Drive Market Growth

The increasing incidence of head and neck cancer is expected to propel the growth of the head and neck cancer diagnostics market going forward. Head and neck cancer is a group of tumors affecting the head and neck region's tissues and organs. These malignancies include the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Head and neck cancer diagnostics help head and neck cancer patients diagnose the disease early with various tests, including an incisional biopsy and a barium swallow test. For instance, in February 2023, according to the American Society of Clinical Oncology, a US-based professional organization for physicians and oncology professionals, Head and neck cancer made up 4% of all malignancies in the US. Head and neck cancer is predicted to affect 66,920 people in the USA in 2023 (49,190 men and 17,730 women). In 2020, head and neck cancer will affect 562,328 people worldwide. Furthermore, according to head and neck cancer in Australia statistics, there were 5,189 new head and neck cancer cases in 2022. Therefore, the rise in head and neck cancer incidence is driving the growth of the head and neck cancer diagnostics market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12016&type=smp

Prominent Trend - Product Innovations Transforming The Head And Neck Cancer Diagnostics Market

Product innovation has emerged as a key trend gaining popularity in the head and neck cancer diagnostic market. Major market players are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Alkem Laboratories Ltd., an India-based healthcare company, launched Cetuxa, the world's first biosimilar for head and neck cancer treatment. Cetuxa is biosimilar to cetuximab, a monoclonal antibody that inhibits the receptor-dependent transduction pathway and has anti-tumor properties. The epidermal growth factor receptor (EGFR) 's extracellular domain is where cetuximab binds. Chemotherapy or radiation therapy is frequently combined with cetuximab in clinical practice. Squamous cell carcinoma of the head and neck that is locally advanced, recurring, or metastatic may be treated with it.

Head And Neck Cancer Diagnostics Market Players
Major companies operating in the head and neck cancer diagnostics market report are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-diagnostics-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the head and neck cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Head And Neck Cancer Diagnostics Market Report Structure
3. Head And Neck Cancer Diagnostics Market Trends And Strategies
4. Head And Neck Cancer Diagnostics Market - Macro Economic Scenario
5. Head And Neck Cancer Diagnostics Market Size And Growth
…..
27. Head And Neck Cancer Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.